Clinical Significance of Serum Soluble Fas, Fas Ligand and Fas in Intrahepatic Lymphocytes in Chronic Hepatitis C

Author： Zaki Maysaa El Sayed   Auf Fatma Abbas   Ghawalby Nabieh Anwar El   Saddal Nirmeen Mohamed El  

Publisher： Informa Healthcare

ISSN： 0882-0139

Source： Immunological Investigations, Vol.37, Iss.2, 2008-02, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated serum-soluble fas ligand in Histiocytic necrotizing lymphadenitis

By Kato Kei   Ohshima Koichi   Anzai Keizo   Suzumiya Junji   Kikuchia Masahiro  

International Journal of Hematology, Vol. 73, Iss. 1, 2001-01 ,pp. : 84-86

Springer Publishing Company

Access to resources Recommend Favorite

Serum Levels of Soluble Fas in Patients with Multinodular Goiter

By Andrikoula Maria   Kolaitis Nikolaos   Vartholomatos George   Tsatsoulis Agathocles  

Immunological Investigations, Vol. 38, Iss. 5, 2009-07 ,pp. : 398-407

Informa Healthcare

Access to resources Recommend Favorite

Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus?

By Bijl M.   van Lopik T.   Limburg P.C.   Spronk P.E.   Jaegers S.M.H.J.   Aarden L.A.   Smeenk R.J.T.   Kallenberg G.G.M.  

Journal of Autoimmunity, Vol. 11, Iss. 5, 1998-10 ,pp. : 457-463

Academic Press

Access to resources Recommend Favorite

Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8 + Fas (CD95) + T lymphocytes

By Ferrone S.  

International Immunology, Vol. 12, Iss. 2, 2000-02 ,pp. : 195-203

Oxford University Press

Access to resources Recommend Favorite

Fas ligand and silicosis

By O'Neill L.  

Trends in Immunology, Vol. 22, Iss. 9, 2001-09 ,pp. : 479-479

Elsevier

Access to resources Recommend Favorite